Study To Evaluate The Effect Of Isotretinoin On Immune Activation In Hiv With Lower Cd4+ T Cell Counts On Suppressive Antiretroviral Treatment
Posted Date: May 15, 2019
- Investigator: Carl Fichtenbaum
- Type of Study: Drug
This study is being done to find out if taking a high dose of isotretinoin is safe and well-tolerated in people infected with HIV who are on anti-HIV medication. Isotretinoin is a drug that is approved to treat severe acne. Your immune system helps your body fight infections. We know that HIV infe
Criteria:
You Are Being Asked To Take Part In This Research Study Because You Are Age 18 To 80 Years Of Age, A
Keywords:
Aids, Hiv, Immune Activation, Inflammation, Isotretinoin
For More Information:
Tammy Miller
513-584-8873
tammy.miller@uc.edu